IPCA Laboratories Share Price

ABOUT IPCA Laboratories

• Industry Biotechnology & Drugs
• ISIN INE571A01038
• BSE Code 524494
• NSE Code IPCALAB

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The products of the Company are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing API’s and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Pharma Nigeria Ltd., Trophic Wellness Pvt. Ltd.

MANAGEMENT

• Premchand Godha Executive Chairman of the Board
• Pranay Godha Chief Executive Officer, Managing Director, Executive Director
• Ajit Jain Chief Financial Officer, Managing Director, Executive Director
• Pabitra Bhattacharya President - Operations (API)
• Sunil Ghai President - Marketing
• Sanjay Kapadia President - Corporate Quality Assurance
• Ashok Kumar President - Research and Development (Chemicals)
• Shailesh Laul President - Operations (Formulations)
• Hitesh Maheshwari President - Research and Development (Formulations)
• Shashil Mendonsa President - International Marketing